The Agriculture Improvement Act of 2018, better known as the Farm Bill, is not a document most people read. It runs over 800 pages and is concerned mostly with the routine mechanics of American agriculture: crop insurance, nutrition assistance, conservation programs. Tucked inside it is a definitional paragraph that, quite apart from anything else the bill did, reorganized an entire corner of the plant economy.
That paragraph did two things. It removed "hemp" from the federal Controlled Substances Act, and it defined hemp as theCannabis sativa L. plant and its derivatives with a delta-9 THC concentration of not more than 0.3% on a dry-weight basis. Everything that followed — the explosion of hemp-derived products, the industry debates over acid-form cannabinoids, the state-by-state regulatory scramble — traces back to those two sentences.
What changed in federal law
Before 2018, all Cannabis sativa was a Schedule I controlled substance under federal law. Schedule I is the most restricted category; it includes compounds the Drug Enforcement Administration classifies as having no accepted medical use and a high potential for abuse. The practical result was that any commercial hemp activity, including the cultivation of seeds and fiber for entirely non-consumable purposes, required an exceptional path through federal regulation.
The 2018 bill carved out hemp — defined by that 0.3% delta-9 THC threshold — from the Controlled Substances Act entirely. It moved regulatory authority primarily to the United States Department of Agriculture, with state departments of agriculture submitting production plans for USDA approval. Hemp became, in a federal sense, a crop like any other.
The delta-9 threshold and the acid-form question
The 2018 definition referred specifically to delta-9 THC. Plant scientists know that in a living hemp flower, very little THC exists in the delta-9 form; most of it is present as the acidic precursor, THCA, which is not psychoactive in its raw state but converts to delta-9 THC when exposed to sustained heat.
This drafting detail created a regulatory surface that producers and retailers navigated in different ways. Some states and some federal agencies interpreted the Farm Bill's threshold to apply to delta-9 THC exclusively — meaning a flower could contain substantial THCA and still qualify as hemp, provided delta-9 THC stayed under 0.3% at the point of testing. Other jurisdictions adopted "total THC" interpretations, which included a conversion factor for THCA. Agricultural testing under USDA guidance generally used total THC; some state retail frameworks did not.
The split in interpretation mattered because it determined what products could legally cross state lines, what pre-harvest testing looked like, and ultimately which consumer categories existed at all.
What the 2018 bill did not do
A common misreading, still everywhere in popular coverage, is that the 2018 Farm Bill legalized cannabis at the federal level. It did not. Anything above the 0.3% delta-9 THC threshold remained a Schedule I controlled substance. State-legal adult-use and medical programs continued to operate in federal-legal limbo, protected primarily by Department of Justice enforcement priorities rather than by changes in the underlying statutes.
The bill also did not preempt state authority. States retained the ability to regulate hemp more strictly than federal law, to ban specific cannabinoids or product formats, and to impose testing, packaging, and age-restriction requirements. The patchwork that followed — where a product fully legal in one state is banned two states away — is a direct product of this design.
The 2026 federal update
In November 2025, Congress passed and the President signed legislation amending the federal definition of hemp. The amendment redefines the threshold as 0.3% total THC on a dry-weight basis, rather than 0.3% delta-9 THC specifically. The change takes effect November 12, 2026, giving the industry approximately twelve months to transition.
The practical implication is significant. "Total THC" calculations apply a molar conversion factor to THCA: specifically, the equation delta-9 THC + (THCA × 0.877). The 0.877 factor accounts for the mass difference between THCA and delta-9 THC after decarboxylation. Under the new definition, a flower with high THCA content that formerly qualified as federal hemp may exceed the 0.3% ceiling and therefore no longer qualify.
Industry observers expect several downstream effects:
- Consumer products formulated around high-THCA chemotypes will need to be reformulated, discontinued, or restricted to state-legal adult-use channels.
- Craft operators will likely pivot toward CBD-dominant and CBG-dominant genetics, or toward multi-cannabinoid blends that keep total THC under the new ceiling.
- Pre-harvest testing protocols, already divided by interpretation, will consolidate around the total-THC standard.
- State legal frameworks will need to be updated or harmonized to reflect the federal change, with a likely spike in state-level legislative activity through mid-2026.
Why any of this matters
Agricultural policy rarely reaches a consumer audience, but the cannabinoid industry is an unusual case: a consumer-facing sector almost entirely shaped by the exact phrasing of a single definitional clause. Producers, retailers, and consumers who pay attention to the text of the bills themselves tend to navigate the transitions better than those who rely on industry summaries.
For a longer look at how producers adapt to these shifts, see our essay on indoor versus outdoor cultivation, which touches on the production-side trade-offs that the new chemistry constraints will force.
